Nebenwirkungen · Abrysvo
Abrysvo powder and solvent for solution for injection Abrysvo powder and solvent for solution for injection in multidose container Respiratory syncytial virus vaccine (bivalent, recombinant) · Abschnitt 4.8 · PDF-Seite 6
HOS-150901 · Präparat HOS-100410
Blood and lymphatic system disorders Lymphadenopathy Rare Immune system disorders Hypersensitivity reactions (includes rash, Rare urticaria) Anaphylaxis Very rare Nervous system disorders Headache Very common Guillain-Barré syndrome Very rare Musculoskeletal and connective tissue disorders Myalgia Very common Arthralgia Very common General disorders and administration site conditions Fatigue Very common Vaccination site pain Very common Vaccination site redness Common Vaccination site swelling Common Pyrexia Uncommon Vaccination site pruritus Rare Vaccination site bruising Rare Vaccination site haematoma Rare
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-14T08:35:00Z · SHA-256 f35f8d66cc17ad69b294df5fef1659ab055ce8cc61b4d8d43ed5c5696af3273a · Passage f6670dc9df91c998d3aa2bb4569b34b314c6a36fcc8fafdd9c53cbdb81b14e43 · Zeichen 1349–2537 im Abschnitt